Effectiveness of interferon-beta and temozolomide combination therapy against temozolomide-refractory recurrent anaplastic astrocytoma

World Journal of Surgical Oncology

Volumn 5, Issue , 2007, Pages

  Fujimaki, Takamitsu ^a   Ishii, Hisato ^b   Matsuno, Akira ^a   Arai, Hajime ^b   Nakagomi, Tadayoshi ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BETA INTERFERON; FLUORODEOXYGLUCOSE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NIMUSTINE; PROCARBAZINE; STEROID; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ARTICLE; BRAIN RADIATION; BRAIN SURGERY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; DRUG SENSITIVITY; FOLLOW UP; GLIOBLASTOMA; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARNOFSKY PERFORMANCE STATUS; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; RECURRENT CANCER; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 34548786267     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-5-89     Document Type: Article

References (21)

1. Nishikawa R Shibui S Maruno M Sugiyama K Sato S Fujimaki T Takahashi H Wakabayashi T Takahashi J Kochi M Nakamura H Sawamura Y Ikeda J Hori T Aoki T Matsutani M Efficacy and safety of monotherapy with temozolomide in patients with anaplastic astrocytoma at first relapse - a phase II clinical study. Gan To Kagaku Ryoho 2006, 33:1279-1285. 16969025
2. Yung WK Prados MD Yaya-Tur R Rosenfeld SS Brada M Friedman HS Albright R Olson J Chang SM O'Neill AM Friedman AH Bruner J Yue N Dugan M Zaknoen S Levin VA Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group. J Clin Oncol 1999, 17:2762-2771. 10561351
3. Hegi ME Diserens AC Gorlia T Hamou MF de Tribolet N Weller M Kros JM Hainfellner JA Mason W Mariani L Bromberg JE Hau P Mirimanoff RO Cairncross JG Janzer RC Stupp R MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005, 352:997-1003. 10.1056/ NEJMoa043331 15758010
4. Natsume A Ishii D Wakabayashi T Tsuno T Hatano H Mizuno M Yoshida J IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 2005, 65:7573-7579. 16140920
5. Park JA Joe YA Kim TG Hong YK Potentiation of antiglioma effect with combined temozolomide and interferon-beta. Oncol Rep 2006 16:1253-1260. 17089046
6. Brell M Tortosa A Verger E Gil JM Vinolas N Villa S Acebes JJ Caral L Pujol T Ferrer I Ribalta T Graus F Prognostic significance of O6-Methylguanine-DNA Methyltransferase determined by promoter hypermethylation and immunohistochemical expression in anaplastic gliomas. Clin Cancer Res 2005 11:5167-5174. 10.1158/ 1078-0432.CCR-05-0230 16033832
7. Brada M Hoang-Xuan K Rampling R Dietrich PY Dirix LY Macdonald D Heimans JJ Zonnenberg BA Bravo-Marques JM Henriksson R Stupp R Yue N Bruner J Dugan M Rao S Zaknoen S Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse. Ann Oncol 2001, 12:259-266. 10.1023/A:1008382516636 11300335
8. Groves MD Puduvalli VK Chang SM Conrad CA Gilbert MR Tremont-Lukats IW Liu TJ Peterson P Schiff D Cloughesy TF Wen PY Greenberg H Abrey LE DeAngelis LM Hess KR Lamborn KR Prados MD Yung WK A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme. J Neurooncol 2007, 81:271-277. 10.1007/s11060-006-9225-y 17031561
9. Brandes AA Tosoni A Cavallo G Bertorelle R Gioia V Franceschi E Biscuola M Blatt V Crino L Ermani M Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: Phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO). Br J Cancer 2006, 95:1155-1160. 10.1038/sj.bjc.6603376 17024124
10. Wick W Steinbach JP Kuker WM Dichgans J Bamberg M Weller M One week on/ one week off: A novel active regimen of temozolomide for recurrent glioblastoma. Neurology 2004, 62:2113-2115. 15184628
11. Kong DS Lee JI Kim WS Son MJ Lim do H Kim ST Park K Kim JH Eoh W Nam DH A pilot study of metronomic temozolomide treatment in patients with recurrent temozolomide-refractory glioblastoma. Oncol Rep 2006, 16:1117-1121. 17016602
12. Kuroki M Tanaka R Suzuki Y Moriyama M Kuwabara Y Kobayashi S Antitumor effect of recombinant murine interferon-beta against mouse malignant glioma. J Interferon Res 1987, 7:301-311. 3497213
13. Chamberlain MC Tsao-Wei DD Groshen S Salvage chemotherapy with cyclophosphamide for recurrent temozolomide-refractory anaplastic astrocytoma. Cancer 2006, 106:172-179. 10.1002/cncr.21582 16323194
14. Kanzawa T Bedwell J Kondo Y Kondo S Germano IM Inhibition of DNA repair for sensitizing resistant glioma cells to temozolomide. J Neurosurg 2003, 99:1047-1052. 14705733
15. Wakabayashi T Kajita Y Mizuno M Nagasaka T Yoshida J Efficacy of adjuvant therapy with procarbazine, MCNU, and vincristine for oligodendroglial tumors. Neurol Med Chir (Tokyo) 2001, 41:115-119. 10.2176/nmc.41.115 11372553
16. Rosenblum MG Yung WK Kelleher PJ Ruzicka F Steck PA Borden EC Growth inhibitory effects of interferon-beta but not interferon-alpha on human glioma cells: Correlation of receptor binding, 2',5'-oligoadenylate synthetase and protein kinase activity. J Interferon Res 1990, 10:141-151. 2140395
17. Hong YK Chung DS Joe YA Yang YJ Kim KM Park YS Yung WK Kang JK Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development. Clin Cancer Res 2000, 6:3354-3360. 10955823
18. Singh RK Gutman M Bucana CD Sanchez R Llansa N Fidler IJ Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas. Proc Natl Acad Sci USA 1995, 92:4562-4566. 41984 7753843 10.1073/pnas.92.10.4562
19. Kodera T Kubota T Kabuto M Nakagawa T Takeuchi H Arishima H Sato K Kobayashi H Kitabayashi M Hirose S Analysis of the proliferative potential of tumor cells after stereotactic radiosurgery for recurrent astrocytic tumors. Neurol Res 2000, 22:802-808. 11149242
20. Ross DA Sandler HM Balter JM Hayman JA Archer PG Auer DL Imaging changes after stereotactic radiosurgery of primary and secondary malignant brain tumors. J Neurooncol 2002, 56:175-181. 10.1023/A:1014571900854 11995819
21. Graves EE Nelson SJ Vigneron DB Verhey L McDermott M Larson D Chang S Prados MD Dillon WP Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neuroradiol 2001, 22:613-624. 11290467